|KIND-030 – Parvovirus in dogs
|Tirnovetmab (IL31 Antibody) – Atopic dermatitis in dogs
|IL4R Antibody – Atopic dermatitis in dogs
|Anti-TNFα Antibody* – Inflammatory bowel disease in dogs
Other pipeline candidates in development (partial list) include KIND-bodies, IgE antibody, CD20 antibody, VEGF antibody, and Checkpoint Inhibitors.
Pipeline Disclaimer: This material is intended to provide investors with information about KindredBio’s clinical development pipeline and is not intended for promotional purposes.